Cite
Burke MJ, Devidas M, Chen Z, et al. Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232. Leukemia. 2021;doi: 10.1038/s41375-021-01460-6.
Burke, M. J., Devidas, M., Chen, Z., Salzer, W. L., Raetz, E. A., Rabin, K. R., Heerema, N. A., Carroll, A. J., Gastier-Foster, J. M., Borowitz, M. J., Wood, B. L., Winick, N. J., Carroll, W. L., Hunger, S. P., Loh, M. L., & Larsen, E. C. (2021). Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232. Leukemia, . https://doi.org/10.1038/s41375-021-01460-6
Burke, Michael J, et al. "Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232." Leukemia vol. (2021). doi: https://doi.org/10.1038/s41375-021-01460-6
Burke MJ, Devidas M, Chen Z, Salzer WL, Raetz EA, Rabin KR, Heerema NA, Carroll AJ, Gastier-Foster JM, Borowitz MJ, Wood BL, Winick NJ, Carroll WL, Hunger SP, Loh ML, Larsen EC. Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232. Leukemia. 2021 Nov 01; doi: 10.1038/s41375-021-01460-6. Epub 2021 Nov 01. PMID: 34725453.
Copy
Download .nbib